Johnson & Johnson Aktie

243,43USD -1,12USD -0,46%
Johnson & Johnson für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 853260 / ISIN: US4781601046

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 141 700 152 700 131 900 139 800 140 800
Umsatz pro Mitarbeiter in Mio. EUR 0,66 0,62 0,65 0,64 0,67

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 60 979 55 294 53 495 55 893 55 624
Summe Anlagevermögen 121 039 132 084 114 063 124 211 143 586
Summe Aktiva 182 018 187 378 167 558 180 104 199 210

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 107 995 110 574 98 784 108 614 117 666
Summe Eigenkapital 74 023 76 804 68 774 71 490 81 544
Summe Passiva 182 018 187 378 167 558 180 104 199 210

Adresse

One Johnson & Johnson Plaza, 08933 New Brunswick
Telefon +1 (732) 524-0400
Internet http://www.jnj.com

Management

Anne M. Mulcahy
Independent Director
Daniel E. Pinto
Director
Darren Snellgrove
Vice President-Investor Relations
Elizabeth Forminard
Chief Legal Officer & Executive Vice President
Eugene A. Woods
Independent Director
George Davy
Director-Global Human Resources
Hubert Joly
Independent Director
James D. Swanson
Chief Information Officer & Executive VP
Jennifer A. Doudna
Independent Director
Jennifer L. Taubert
EVP & Worldwide Chairman-Innovative Medicine
Jessica Moore
Group Chief Financial Officer-Innovative Medicine
Joaquin Duato
Chairman & Chief Executive Officer
John C. Reed
Executive Vice President-Innovative Medicine
John George Morikis
Independent Director
Jonathan Sheh
Director-Workplace Experience
Joseph J. Wolk
Chief Financial Officer & Executive Vice President
Juliana Clawson
Head-Organization Change Management
Kathryn E. Wengel
Chief Technical Operations & Risk Officer
Kristen Blair Mulholland
Chief Human Resources Officer & Executive VP
Marc Larkins
Secretary & Vice President-Governance
Marillyn A. Hewson
Lead Independent Director
Mark Alan Weinberger
Independent Director
Mark B. McClellan
Independent Director
Mary C. Beckerle
Independent Director
Michael Bzdak
Global Dir-Employee Engagement-Global Cmnty Impact
Nadja Y. West
Independent Director
Paula A. Johnson
Independent Director
Penny M. Heaton
Chief Medical Officer
Robert J. Decker
Chief Accounting Officer & Controller
Ronald A. Kapusta
Chief Accounting Officer & Controller
Thomas J. Spellman
Secretary
Timothy Schmid
Executive Vice President & Chairman-Worldwide